Editor(s):
(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.
Reviewers:
(1) Ankan Kumar Paul, Barts Health NHS Trust, UK.
(2) Lamia Mohamed-Nabil Ismail, Cairo University, Egypt.
Additional Reviewers:
(1) Leonardo Rufino Garcia, Universidade Estadual Paulista, Brazil.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.75/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Ankan Kumar Paul, UK) | File 1 | NA
Stage 2 | Peer review report_2 (Lamia Mohamed-Nabil Ismail, Egypt) | File 1 | File 2
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA